États-Unis - anglais - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older. important limitations of use: - qvar redihaler is not indicated for the relief of acute bronchospasm. qvar redihaler is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . qvar redihaler is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics

États-Unis - anglais - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

États-Unis - anglais - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

États-Unis - anglais - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

Canada - anglais - Health Canada

pharmaco canada inc. - beclomethasone dipropionate - metered-dose aerosol - 50mcg - beclomethasone dipropionate 50mcg - adrenals

Canada - anglais - Health Canada

ratiopharm inc division of teva canada limited - beclomethasone dipropionate - spray - 50mcg - beclomethasone dipropionate 50mcg - corticosteroids

Canada - anglais - Health Canada

altimed pharma inc. - beclomethasone dipropionate - metered-dose aerosol - 50mcg - beclomethasone dipropionate 50mcg - adrenals

Canada - anglais - Health Canada

prempharm inc - beclomethasone dipropionate - metered-dose aerosol - 50mcg - beclomethasone dipropionate 50mcg - corticosteroids

États-Unis - anglais - NLM (National Library of Medicine)

teva respiratory, llc - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qnasl® nasal aerosol is indicated for the treatment of the nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older. qnasl nasal aerosol is contraindicated in patients with a history of hypersensitivity to beclomethasone dipropionate and/or any other qnasl nasal aerosol ingredients [see warnings and precautions (5.3)] . teratogenic effects : pregnancy category c there are no adequate and well-controlled clinical trials in pregnant women treated with qnasl nasal aerosol. beclomethasone dipropionate was teratogenic and embryocidal in the mouse and rabbit although these effects were not observed in rats. qnasl nasal aerosol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. experience with oral corticosteroids since their introduction in pharmacologic, as opposed to physiologic, doses suggests that rodents are more prone to teratogenic effects from corticosteroids than humans. beclomethasone dipropionate ad

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glenmark pharmaceuticals (malaysia) sdn. bhd. - beclomethasone dipropionate; salbutamol sulphate -